1. P-526 Targeting histone modifications: H3K27 acetylation regulates the expression of genes involved in key processes of uterine leiomyoma pathogenesis. (30th June 2022) Authors: Carbajo-García, M C; de Miguel-Gómez, L; Juárez-Barber, E; Trelis, A; Monleón, J; Pellicer, A; Flanagan, J; Ferrero, H Journal: Human reproduction Issue: Volume 37(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P58 Differential molecular diagnosis of uterine leiomyomas and leiomyosarcomas using DNA and RNA sequencing. (1st November 2019) Authors: Mas, A; Alonso, R; Escorcia, P; Jimenez-Almazán, J; Monleón, J; Montero, B; Lago, V; Simón, C Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A92 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P–543 Inhibition of cell proliferation and extracellular matrix formation in human uterine leiomyomas by 5-aza–2'-deoxycitidine via Wnt/ β-catenin pathway. (6th August 2021) Authors: Carbajo-García, M C; Corachán, A; Segura, M; Monleón, J; Escrig, J; Faus, A; Pellicer, A; Cervelló, I; Ferrero, H Journal: Human reproduction Issue: Volume 36:Supplement 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗